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Abstract: BACKGROUND Case fatality and poor outcome rates are different between brain arteri-
ovenous malformation associated intracerebral hemorrhage (bAVM-ICH) and spontaneous intracerebral
hemorrhage (SICH). These outcome rates, however, have never been compared in patients who need neu-
rosurgical evacuation of the intracerebral hemorrhage (ICH). OBJECTIVE To compare the short- and
long-term functional outcome between surgically treated patients with bAVM-ICH and SICH. METHODS
We collected data from surgically treated ICH patients at the department of neurosurgery, University
hospital Zurich, from January 2015 to July 2018. We performed logistic regression analysis to compare the
functional outcome between groups, adjusting for demographics, admission characteristics and stroke risk
factors. RESULTS A total of 26 bAVM-ICH and 115 SICH patients were included in the final analysis.
Patients with bAVM-ICH were younger and less likely to have hypertension without significant differences
in ICH volume, hematoma location, intraventricular hemorrhage and other stroke risk factors. A signifi-
cantly better functional outcome rate was seen in bAVM-ICH patients at short- and long-term follow-up.
These differences remained significant after adjusting for confounders. CONCLUSIONS Patients with a
bAVM who need surgical evacuation of an ICH have a more favorable outcome than surgically treated
patients with spontaneous ICH, even after correction for confounding factors, such as younger age and
less premorbid hypertension.
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-BACKGROUND: Case fatality and poor outcome
rates are different between brain arteriovenous
malformationLassociated intracerebral hemorrhage
(bAVM-ICH) and spontaneous intracerebral hemorrhage
(SICH). These outcome rates, however, have never been
compared in patients who need neurosurgical evacuation
of the intracerebral hemorrhage (ICH).
-OBJECTIVE: To compare the short- and long-term func-
tional outcome between surgically treated patients with
bAVM-ICH and SICH.
-METHODS: We collected data from surgically treated
ICH patients at the Department of Neurosurgery, University
Hospital Zurich, from January 2015 to July 2018. We
performed logistic regression analysis to compare the
functional outcome between groups, adjusting for
demographics, admission characteristics, and stroke risk
factors.
-RESULTS: A total of 26 bAVM-ICH and 115 SICH patients
were included in the final analysis. Patients with bAVM-ICH
were younger and less likely to have hypertension without
significant differences in ICH volume, hematoma location,
intraventricular hemorrhage, and other stroke risk factors.
A significantly better functional outcome rate was seen in
bAVM-ICH patients at short- and long-term follow-up. These
differences remained significant after adjusting for
confounders.
-CONCLUSIONS: patients with a bAVM who need
surgical evacuation of an ICH have a more favorable
outcome than surgically treated patients with spontaneous
ICH, even after correction for confounding factors, such as
younger age and less premorbid hypertension.
INTRODUCTION
I
ntracerebral hemorrhage (ICH) is a devastating disease that
can lead to high mortality and morbidity. The incidence of
ICH is approximately 25 per 100,000 person-years, and it has
a mortality of 40% within 1 month of presentation. ICH can be
classified as primary or secondary, depending on the etiology of
hemorrhage. Primary ICH is most commonly caused by chronic
arterial hypertension, whereas secondary ICHs are caused by
underlying lesions, such as aneurysms, vascular malformations, or
tumors.1
A brain arteriovenous malformation (bAVM) is a vascular
malformation, which most often causes clinically significant ICH.
Although the incidence of bAVM is rare, about 1.12e1.42 per
100,000 person-years, bAVM-associated ICH (bAVM-ICH) has a
high impact on the socioeconomic and health care system.2-5 The
annual risk of bAVM-ICH is approximately 2.3%, which increases
to a rate of 4.8% after a previous hemorrhage.6-8 Reported case
fatality and poor outcome rates after bAVM-ICH range between 5%
and 25% and 10% and 30%, respectively.3,9-11 This is lower than
reported outcomes after spontaneous ICH (SICH), with a mortality
rate of 35%52% in 30 days and 15%30% independent func-
tional outcome after 1 year.3,12-17 Recently, the arteriovenous
malformationrelated intracerebral hemorrhage score was exter-
nally validated and showed better performance in predicting






bAVM: Brain arteriovenous malformation
GCS: Glasgow Coma Scale
ICH: Intracerebral hemorrhage
mRS: Modified Rankin Scale
SICH: Spontaneous intracranial hemorrhage
From the 1Department of Neurosurgery, 2Clinical Neuroscience Center, and 3Department of
Neuroradiology, University Hospital Zurich, Zurich, Switzerland
To whom correspondence should be addressed: Menno R. Germans, M.D., Ph.D.
[E-mail: Menno.Germans@usz.ch]
Wenhua Sun and Menno R. Germans contributed equally to the manuscript.




1878-8750/ª 2021 The Authors. Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).
WORLD NEUROSURGERY 139: e807-e811, JULY 2020 www.journals.elsevier.com/world-neurosurgery e807
Original Article
treatment and management decisions, as well as providing
information about the prognosis after bAVM-ICH, should
probably not be based on the results from SICH.
There have been some studies on comparison of morbidity and
mortality of bAVM-ICH and SICH and showed that patients with
bAVM-ICH have a more favorable outcome than patients with
SICH from other causes, independent of patient age and other
known predictors of ICH outcome.3,5 These studies included all
various causes of ICH including intracranial aneurysms and the
patients in both good and poor clinical admission status.5,19
However, patients who need surgical evacuation of their ICH are
generally in worse clinical condition at admission, which has
influenced the clinical outcome. No studies that directly
compared the clinical outcome of surgically treated bAVM-ICH
with surgically treated SICH were found. We aimed to investi-
gate whether surgically treated patients with bAVM-ICH fare better
than SICH patients regarding short- and long-term functional
outcomes.
METHODS
Study Design and Data Collection
We performed a retrospective analysis of prospectively collected
patient data of patients who underwent semiemergent (within 1
week after diagnosis) neurosurgical evacuation of their ICH at the
department of neurosurgery, University Hospital Zurich from
January 2015 to July 2018. Patients younger than 18 years and pa-
tients with ICH due to traumatic brain injury or cerebrovascular
diseases other than bAVM, such as a ruptured intracranial
aneurysm, were excluded.
Baseline data consisted of patient characteristics, hematoma
parameters, and outcome variables, according to the review article
of van Beijnum et al.3 Patient characteristics included age, sex,
Glasgow Coma Scale (GCS), and systolic and diastolic blood
pressure at admission. GCS was divided into 3 groups according
to arteriovenous malformationrelated intracerebral hemorrhage
score.20 Hematoma parameters included location (cortical vs.
deep vs. infratentorial), side and size (measured by the ABC/2
method in native brain CT), and presence of intraventricular
hemorrhage (IVH).21 Outcome variables included case fatality
and modified Rankin Scale (mRS, assessed by trained
physicians) at 6 weeks, 6 months, and 12 months after
treatment. A mRS of 3 was defined as a poor outcome.
Missing data were retrospectively collected from our hospital
information system and telephone interviews with the patient or
general practitioner. Ethical approval for this study was obtained
from the local committee (BASEC number: PB_2017-00093).
Informed consent for collecting data for scientific purposes was
retrieved through a general consent form, which patients have
signed.
Statistical Analysis
The differences in baseline characteristics between the 2 groups
were evaluated with Pearson c2 test for categorical variables.
Continuous variables were compared using parametric statistics
when data showed normal distribution and nonparametric
statistics when they did not. We compared outcomes using odds
ratios (ORs) with 95% confidence intervals (CIs) at 6 weeks and 6
and 12 months after surgery. The differences were considered
significant at a P value of < 0.05.
Multivariate logistic regression analysis was performed to
evaluate the association between bAVM-ICH and SICH outcomes,
with a backward elimination procedure to identify significant
confounders. Cutoff values of P < 0.1 were used to select the
initial set of variables to be included in the initial multivariable
model. All statistical analyses were performed with the SPSS
statistical software package (IBM SPSS Statistics, version 25).
RESULTS
Baseline Characteristics
In total, 31 bAVM-ICH and 115 SICH patients were extracted from
the database. Five bAVM-ICH patients were excluded since they
had their surgical treatment more than 1 week after hemorrhage.
One SICH patient was lost to follow-up after the 6-weeks’ outcome
assessment due to emigration and is therefore not included in the
6-months’ and 12-months’ outcome analysis. The final analysis
included 26 bAVM-ICH and 115 SICH patients.
Baseline characteristics are shown in Table 1.
Patients with bAVM-ICH were significantly younger (45.5  17.9
vs. 61.6  14.3 years, P < 0.001) and less likely to have premorbid
hypertension (32.3% vs. 54.8%, P ¼ 0.026) compared with SICH
patients. There were no significant differences in sex, ICH volume,
hematoma location, intraventricular hemorrhage, and other stroke
risk factors, such as diabetes mellitus and hyperlipidemia between
studied groups.
Functional Outcome and Case Fatality
Table 2 and Figure 1 present the results of the outcome analysis.
Multivariate analysis was done including the following
parameters: age, side, hypertension, and diabetes mellitus. The
proportion of SICH patients who were dead or dependent (mRS 
3) was significantly higher than bAVM-ICH patients at short- and
long-term follow-up. After stratified analysis, the rate of death or
dependence remained significantly higher in SICH patients at all
follow-up timepoints. There was no difference in case fatality
between groups at any follow-up timepoint (Table 3).
DISCUSSION
In our study, we found that patients with bAVM-ICH showed
better functional outcome compared with SICH patients at short-
term (6 weeks) and long-term (6 and 12 months) follow-up. We
concluded that bAVM patients who need semiemergent surgical
evacuation of their ICH have a better prognosis than surgically
treated patients with SICH. Our data suggest that treatment and
management decisions, as well as information about the prog-
nosis after bAVM-ICH, should not be based on results of SICH
research.
Our study consolidated findings from previous studies that have
found a better outcome after bAVM-ICH compared with SICH.2-5
Our study, however, only included ICH patients who needed
surgical evacuation of the ICH, indicating patients in a more se-
vere clinical condition. This is reflected in the worse GCS at
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admission in our study as compared with the study of van Beijnum
et al3 (median GCS 8 vs. 15).
Patients with bAVM-ICH are younger than SICH patients and
bear fewer risk factors, which can affect outcome after ICH, such
as hypertension and diabetes mellitus. Nevertheless, even after
adjusting for those confounders the patients with bAVM-ICH
remained having a more favorable functional outcome.22-24 One
reason for a better prognosis in bAVM patients is that the
malformation mostly ruptures within the nidus itself or in the
venous side of malformation, leading to a bleeding with lower
pressure instead of acute arterial hemorrhage due to hyperten-
sion.5,22-24 Secondly, a significant part, or even the complete,
bAVM is located in a sulcus, leading to a sulcal hemorrhage with
less damage of the brain parenchyma than SICH, except for the
Table 1. Baseline Characteristics of Brain Arteriovenous Malformation-Associated Intracerebral Hemorrhage and Spontaneous
Intracerebral Hemorrhage Patients
bAVM-ICH (n [ 26) SICH (n [ 115) P Value
Female gender 11 (42.3) 54 (47.0) 0.828
Age, years (SD) 46.3  17.7 61.6  14.3 <0.001
Side of hematoma (right) 12 (46.2) 70 (60.9) 0.059
History of hypertension 8 (30.8) 63 (54.8) 0.027
Diabetes mellitus 4 (15.4) 35 (30.4) 0.121
Hyperlipidemia 3 (11.5) 33 (28.7) 0.070
Admission GCS 0.259
3e4 10 (38.5) 38 (33.0) 0.767
5e12 14 (53.8) 52 (45.2) 0.563
13e15 2 (7.7) 25 (21.7) 0.171
Admission SBP, mm Hg (SD) 159.8  26.2 153.4  28.6 0.243
Admission DBP, mm Hg (SD) 89.3  25.4 87.82  18.9 0.760
Hematoma location
Supratentorial 22 (87.1) 88 (76.5) 0.173
Cortical 11 (42.3) 60 (52.2) 0.303
Deep 11 (42.3) 28 (24.3) 0.489
Infratentorial 4 (15.4) 27 (23.5) 0.108
ICH volume >30 cm3 4 (15.4) 19 (16.5) 0.173
Intraventricular hemorrhage 7 (26.9) 25 (21.7) 0.569
All parameters are presented in numbers with percentages between brackets, unless otherwise stated.
bAVM-ICH, brain arteriovenous malformationassociated intracerebral hemorrhage; SICH, spontaneous intracerebral hemorrhage; SD, standard deviation; GCS, Glasgow Coma Scale; SBP,
systolic blood pressure; DBP, diastolic blood pressure.
Table 2. Poor Outcome (Modified Rankin Scale 3) in Brain Arteriovenous MalformationAssociated Intracerebral Hemorrhage and
Spontaneous Intracerebral Hemorrhage
Interval bAVM-ICH (n [ 26) SICH* (n [ 115) OR (95% CI) Adjusted ORy (95% CI)
6 weeks 19 (73.1) 107 (93.0) 0.20 (0.07e0.63) 0.28 (0.08e0.96)
6 months 16 (61.5) 93 (81.5) 0.36 (0.14e0.91) 0.35 (0.13e0.96)
12 months 14 (53.8) 87 (76.3) 0.36 (0.15e0.88) 0.36 (0.14e0.93)
All parameters are presented in numbers with percentages between brackets, unless otherwise stated.
bAVM-ICH, brain arteriovenous malformationassociated intracerebral hemorrhage; ICH, intracerebral hemorrhage; SICH, spontaneous intracerebral hemorrhage; OR, odds ratio; CI, confidence
interval.
*1 patient lost follow-up after 6 weeks post surgery.
yAdjust for age, side of hematoma, history of hypertension, hyperlipidemia.
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compressive effect of the hematoma itself. Another reason might
be the higher proportion of infratentorial hemorrhages in the
SICH group, which is associated with a worse clinical outcome.
Other studies regarding this topic have shown results with more
favorable rates for bAVM-ICH patients at discharge or 1 month
after hemorrhage.3,5 The difference with these studies is explained
by the fact that patients in our study were admitted in worse
clinical condition and needed emergent hematoma evacuation.
One of the limitations of the current study is that, since it is a
single-center study, the sample size of bAVM-ICH is relatively
small, which may have introduced selection bias. In addition, the
indication for surgical evacuation of the ICH was set by the
treating physician, which might also have introduced a selection
bias. In addition, missing data were retrospectively collected from
our hospital information system and telephone interview with the
patient or the general practitioner, which can lead to recall bias,
since they may remember patients’ conditions wrongly at different
time points.
CONCLUSION
Brain AVM patients who need surgical evacuation of an intrace-
rebral hematoma have a more favorable outcome than surgically
treated patients with spontaneous ICH at short- and long-term
follow-up (6 weeks and 12 months), even after correction for
confounding factors, such as younger age and less premorbid
hypertension. A thorough radiologic investigation of the under-
lying pathology of intracerebral hematoma is mandatory to assess
functional outcome after surgical evacuation. We suggest that
treatment and management decisions, as well as information
about the prognosis after bAVM-ICH, should not be based on
results of SICH research.
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Figure 1. Comparison of modified Rankin scale of patients with brain
arteriovenous malformationrelated intracerebral hemorrhage (bAVM-ICH)
and spontaneous intracerebral hemorrhage (SICH) at 6 weeks and 12
months.
Table 3. Case Fatality in Brain Arteriovenous MalformationAssociated Intracerebral Hemorrhage and Spontaneous Intracerebral
Hemorrhage
Interval bAVM-ICH (n [ 26) SICH* (n [ 115) OR (95% CI) Adjusted ORy (95% CI)
6 weeks 4 (15.3) 38 (33.0) 0.37 (0.12e1.14) 0.36 (0.11e1.20)
6 months 8 (30.8) 43 (37.7) 0.73 (0.29e1.83) 0.78 (0.29e2.07)
12 months 8 (30.8) 48 (42.1) 0.61 (0.24e1.52) 0.63 (0.24e1.66)
All parameters are presented in numbers with percentages between brackets, unless otherwise stated.
bAVM-ICH, brain arteriovenous malformationassociated intracerebral hemorrhage; SICH, spontaneous intracerebral hemorrhage; OR, odds ratio; CI, confidence interval.
*1 patient lost follow-up after 6 weeks’ post surgery.
yAdjust for age, side of hematoma, history of hypertension, and hyperlipidemia.
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